Pediatric committee closed session
Executive Summary
Anti-Infective Drugs Pediatric Subcommittee is understood to have considered safety issues related to WellSpring's tin mesoporphyrin (SnMP, stannsoporfin) during a closed session June 12. An NDA filing for hyperbilirubinemia prevention in infants at risk of developing jaundice is expected by first quarter 2004. Pediatric safety data for other investigational products was also discussed...
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.